Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/01/2009US20090249509 Inbred Corn Line BB38
10/01/2009US20090249508 Soybean Cultivar 26074414
10/01/2009US20090249507 Soybean Cultivar 7509171
10/01/2009US20090249506 Soybean Cultivar 7511119
10/01/2009US20090249504 Novel snap pea variety sugar deuce
10/01/2009US20090249502 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer; antibody or antigen-binding fragment thereof that specifically binds to a 193P1E1B protein; drug delivery
10/01/2009US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
10/01/2009US20090247615 TRIGGERED RNAi
10/01/2009US20090247613 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease
10/01/2009US20090247612 Prevention of viral infectivity
10/01/2009US20090247609 Sm-protein based secretion engineering
10/01/2009US20090247607 dsRNA COMPOSITIONS AND METHODS FOR TREATING HPV INFECTION
10/01/2009US20090247606 RNA Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
10/01/2009US20090247482 50 Human Secreted Proteins
10/01/2009US20090247460 Inhibitor of vascular endothelial cell growth factor
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090247448 Mutants with improved detergent stability; use in the textile, detergent and cellulose fiber processing industries
10/01/2009US20090246876 High expression zymomonas promoters
10/01/2009US20090246875 Efficient method for nuclear reprogramming
10/01/2009US20090246867 Glial mitogenic factors, their preparation and use
10/01/2009US20090246859 Methods and Compositions for Purification of Nucleic Acid from a Host Cell
10/01/2009US20090246857 Stable recombinant yeasts for fermenting xylose to ethanol
10/01/2009US20090246856 Trichoderma Reesei Phytase Enzymes, Nucleic Acids Encoding Such Phytase Enzymes, Vectors and Host Cells Incorporating Same and Methods of Making and Using Same
10/01/2009US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/01/2009US20090246854 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
10/01/2009US20090246853 Directed evolution method
10/01/2009US20090246846 Zymomonas with improved xylose utilization
10/01/2009US20090246836 Pgro expression units
10/01/2009US20090246833 Small interfering RNAS as non-specific drugs
10/01/2009US20090246832 Production of polysialic acid containing glycoconjugates using a self-priming polysialyltransferase
10/01/2009US20090246831 Using acid lysis to release translation products from cells
10/01/2009US20090246830 Recombinant influenza viruses for vaccines and gene therapy
10/01/2009US20090246829 Sequence analysis of the tetravalent rotavirus vaccine
10/01/2009US20090246827 Recombinant toxin fragments
10/01/2009US20090246826 Bi-Directional Selection Markers With Improved Activity
10/01/2009US20090246803 Nad biosynthesis systems
10/01/2009US20090246792 Methods for detecting nucleic acid sequence variations
10/01/2009US20090246786 Novel rat voltage-gated potassium channel
10/01/2009US20090246755 Method of examining chemical using gene-disrupted strain
10/01/2009US20090246353 Soybean Cultivar 7535357
10/01/2009US20090246352 Soybean Cultivar S070160
10/01/2009US20090246351 Soybean Cultivar S070158
10/01/2009US20090246349 Wheat pigment
10/01/2009US20090246317 Acyl-coa: ethanol o-acyltransferase/esterase gene and use thereof
10/01/2009US20090246316 Esterase gene and use thereof
10/01/2009US20090246272 Mda-7 proteins and methods of use thereof
10/01/2009US20090246228 Moraxella catarrhalis Proteins
10/01/2009US20090246220 Constructs for enhancing immune responses
10/01/2009US20090246219 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2009US20090246213 Vaccine comprising a polynucleotide encoding an antigen recognized by a cd4+ helper t-cell and a polynucleotide encoding a tumor specific or associated antigen recognized by a cd8+ ctl
10/01/2009US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)
10/01/2009US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009US20090246201 Substances
10/01/2009US20090246194 ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
10/01/2009US20090246192 1D05 PCSK9 antagonists
10/01/2009US20090246189 Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic Neurons
10/01/2009US20090246188 Method for Production of a Bioengineered Form of Tissue Plasminogen Activator
10/01/2009US20090246183 eNOS mutations useful for gene therapy and therapeutic screening
10/01/2009US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/01/2009US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
10/01/2009US20090246129 Compositions and methods for the diagnosis and treatment of tumor
10/01/2009US20090242879 Optoelectronic device and method of fabricating the same
10/01/2009DE102006031764B4 Verfahren zur parallelen Isolierung doppel- und einzelsträngiger Nukleinsäuren sowie zur selektiven Entfernung doppelsträngiger Nukleinsäuren aus einem Gemisch von doppel- und einzelsträngigen Nukleinsäuren A method for parallel isolation of double-and single-stranded nucleic acids and double-stranded nucleic acids for the selective removal of a mixture of double and single stranded nucleic acids
10/01/2009CA2719938A1 Lentivirus-based immunogenic vectors
10/01/2009CA2719765A1 Nucleic and amino acid sequences for the control of pathogen agents
10/01/2009CA2719733A1 Impaired alleles of genes involved in metabolic pathways and methods for detecting and using the same
10/01/2009CA2719718A1 Aberrant mitochondrial dna, associated fusion transcripts and hybridization probes therefor
10/01/2009CA2719559A1 Host cells and methods of producing disulfide bond containing proteins
10/01/2009CA2719553A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009CA2719314A1 Method for amplifying locus in bacterial cell
10/01/2009CA2718850A1 Compositions and methods related to silicon transport
10/01/2009CA2718517A1 Efficient insertion of dna into embryonic stem cells
10/01/2009CA2718137A1 Restriction endonuclease enhanced polymorphic sequence detection
10/01/2009CA2716628A1 Methods and compositions for treating atherosclerosis and related conditions
10/01/2009CA2716590A1 High expression zymomonas promoters
10/01/2009CA2716585A1 Zymomonas with improved xylose utilization
09/2009
09/30/2009EP2105511A1 Medicament compositions and substances for treatment and identifying adenocarcinoma of the lung
09/30/2009EP2105507A1 Deracemisation of amines
09/30/2009EP2105505A1 Methods and materials for the reproducible generation of high producer cell lines for recombinant proteins
09/30/2009EP2105504A2 Genes and proteins, and their use
09/30/2009EP2105503A2 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
09/30/2009EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer
09/30/2009EP2105496A1 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
09/30/2009EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein
09/30/2009EP2105446A2 Cytokine receptor zalpha11
09/30/2009EP2104740A2 Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
09/30/2009EP2104739A2 Modified messenger rna stabilizing sequences for expressing genes in bacterial cells
09/30/2009EP2104738A2 Oligoribonucleotides and uses thereof
09/30/2009EP2104737A2 Functions and targets of let-7 micro rnas
09/30/2009EP2104736A2 Mir-126 regulated genes and pathways as targets for therapeutic intervention
09/30/2009EP2104735A2 Mir-21 regulated genes and pathways as targets for therapeutic intervention
09/30/2009EP2104734A2 Mir-20 regulated genes and pathways as targets for therapeutic intervention
09/30/2009EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
09/30/2009EP1693378B1 Protein nmb1125 and use thereof in pharmaceutical formulations
09/30/2009EP1678308B1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment
09/30/2009EP1572971B1 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
09/30/2009EP1544300B1 Novel glycosyltransferase genes
09/30/2009EP1509605B1 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients
09/30/2009EP1451322B1 Il-21 antagonists
09/30/2009EP1407007B1 Attenuated circovirus
1 ... 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 ... 4023